Skip to main content

Table 2 Histomorphometry data eight weeks after anterior cruciate ligament transection in dogs

From: Tiludronate treatment improves structural changes and symptoms of osteoarthritis in the canine anterior cruciate ligament model

 

Calcified cartilage surface (10 -2 mm 2 )

Subchondral bone surface (10 -2 mm 2 )

Trabecular thickness (10 -2 mm)

Trabecular separation (10 -3 mm)

Placebo-control

16.9 (3.9)

75.1 (9.3)

8.9 (2.3)

86.0 (52.6)

Tiludronate

19.8 (2.3)

86.2 (5.1)*

10.3 (2.0)

45.5 (15.1)*

  1. Tiludronate was injected subcutaneously at 2 mg/kg, starting immediately on the day of ACL transection and repeated every two weeks for an eight-week follow-up. Osteoarthritic placebo-treated dogs received mannitol injection in a similar fashion.
  2. Data presented are mean (SD). * Statistically significant (P < 0.01) compared to placebo-control.
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us